首页|CTA联合血清MMP-9、TIMP-1在缺血性脑卒中诊断中的应用

CTA联合血清MMP-9、TIMP-1在缺血性脑卒中诊断中的应用

扫码查看
目的 探究CT血管成像(CTA)联合血清基质金属蛋白酶9(MMP-9)、金属蛋白酶组织抑制因子1(TIMP-1)在缺血性脑卒中诊断中的应用.方法 选取2021年5月至2022年5月期间张家口市第一医院神经内科收治的140例脑卒中患者作为研究组研究对象,均行CTA检查,以数字血管造影(DSA)为金标准,分析CTA对缺血性脑卒中诊断价值,另选择同期至此院进行体检的健康者80名作为对照组,比较两组患者血清MMP-9、TIMP-1水平.结果 140例患者,共检查463条头颈血管,经CTA诊断无狭窄236条、轻度狭窄66条、中度狭窄36条、重度狭窄46条、闭塞22条,与DSA对照CTA诊断缺血性脑卒中患者血管狭窄程度的灵敏度为81.25%,特异度为90.15%;CTA诊断轻度狭窄患者74例、中度16例、重度46、闭塞4例,与DSA对照CTA诊断灵敏度82.50%、特异度83.33%;研究组患者血清MMP-9、TIMP-1表达水平均显著高于对照组患者,差异有统计学意义(t=73.668、33.925,P<0.05),且研究组患者随着狭窄程度增加,血清MMP-9、TIMP-1水平逐渐上升,差异有统计学意义(F=13298.37、901.001,P<0.05);MMP-9以247.14 ng/mL为临界值,阳性53例,阴性87例;TIMP-1均值(239.21 ng/mL)为临界值,阳性53例,阴性87例;以CTA阳性为基础,MMP-9、TIMP-1任一指标阳性则定义为联合诊断阳性,结果显示联合诊断灵敏度为88.75%,特异度为80.00%.结论 CTA联合血清MMP-9、TIMP-1对缺血性脑卒中诊断效能较高,临床应在密切观察缺血性脑卒中患者CTA检查基础上联合MMP-9、TIMP-1水平检测.
Application of CTA combined with serum MMP-9 and TIMP-1 in the diagnosis of ischemic stroke
Objective To explore the application of CT angiography(CTA)combined with se-rum matrix metalloproteinase 9(MMP-9)and tissue inhibitor of metalloproteinase 1(TIMP-1)in the diagno-sis of ischemic stroke.Methods From May 2021 to May 2022,140 patients with cerebral infarction were ad-mitted to the Department of Neurology at our hospital.They were selected as the study group and had under-gone CTA.Digital subtraction angiography(DSA)was used as the gold standard to analyze the diagnostic val-ue of CTA in ischemic stroke.Additionally,80 healthy individuals who visited the hospital for physical exami-nation during the same period were selected as the control group.Serum MMP-9 and TIMP-1 levels were com-pared between the two groups.Results A total of 463 head and neck vessels were examined in the 140 pa-tients.CTA diagnosed 236 vessels without stenosis,66 with mild stenosis,36 with moderate stenosis,46 with severe stenosis,and 22 with occlusion.Compared with DSA,the sensitivity and specificity of CTA in diagnos-ing vascular stenosis in patients with ischemic stroke were 81.25%and 90.15%.CTA diagnosed 74 cases of mild stenosis,16 cases of moderate stenosis,46 cases of severe stenosis,and 4 cases of occlusion.Compared with DSA,the diagnostic sensitivity and specificity of CTA were 82.50%and 83.33%.In the study group,se-rum MMP-9 and TIMP-1 levels were significantly higher than those in the control group(t=73.668,33.925,P<0.05).As stenosis worsened,serum MMP-9 and TIMP-1 levels increased(F=13298.37,901.001,P<0.05).MMP-9 at 247.14 ng/mL as the critical value,there were 53 positive cases and 87 negative cases.TIMP-1 at 239.21 ng/mL as the critical value resulted in 53 positive cases and 87 negative cases.The sensitivity and specificity of the combined diagnosis were 88.75%and 80.00%.Conclusion CTA combined with serum lev-els of MMP-9 and TIMP-1 can enhance the diagnostic accuracy for ischemic stroke.

Ischemic StrokeCT AngiographySerum Matrix Metalloproteinase 9Tissue Inhibi-tor of Metalloproteinase 1Diagnosis

戴云蛟、贾婕、殷少龙、刘晓翠、徐文利

展开 >

张家口市第一医院神经内一科,河北,张家口 075000

张家口市第一医院放射科,河北,张家口 075000

华北理工大学附属医院神经内科,河北,唐山 063000

沧州中西医结合医院影像三科,河北,沧州 061000

展开 >

缺血性脑卒中 CT血管成像 血清基质金属蛋白酶9 金属蛋白酶组织抑制因子1 诊断

河北省医学科学研究项目

20221903

2024

分子诊断与治疗杂志
中山大学

分子诊断与治疗杂志

CSTPCD
影响因子:0.65
ISSN:1674-6929
年,卷(期):2024.16(5)
  • 11